Mave Health, a Bengaluru-based healthtech startup, has raised an undisclosed seed funding round to accelerate the launch of its flagship wearable device focused on real-time focus enhancement and stress regulation. The funding will support product development, clinical validation, manufacturing scale-up, and initial market entry, positioning Mave to address growing demand for non-invasive mental wellness tools in India’s high-stress workforce and student populations.
Glimpse:
The seed round, backed by prominent early-stage investors and healthtech angels, will fuel the final development and launch of Mave’s AI-powered wearable a lightweight, wrist-worn device that uses EEG-like sensors, biofeedback, and adaptive neurostimulation to monitor cognitive states, detect stress spikes, and deliver personalized interventions (vibration patterns, guided breathing prompts, audio cues) to improve focus and emotional regulation. The company targets professionals, students, and high-pressure professionals, with subscription-free core features and optional premium coaching, aiming for commercial availability in late 2026.
Mave Health, an emerging Bengaluru-based startup specializing in neurotech wearables for mental wellness, has successfully closed a seed funding round to bring its flagship focus and stress regulation device to market. The investment, announced on February 27, 2026, comes from a syndicate of early-stage healthtech investors and prominent angels with deep experience in consumer wearables and digital therapeutics. While the exact amount remains undisclosed, the round is described as significant enough to support full product development, regulatory clearances, pilot manufacturing, and initial go-to-market activities in India.
The core product is a sleek, wrist-worn wearable that combines non-invasive EEG-like sensors, heart rate variability tracking, skin conductance monitoring, and motion analysis to continuously assess the user’s cognitive and emotional state in real time. Using proprietary AI algorithms, the device detects moments of declining focus, elevated stress, or early fatigue, then delivers subtle, personalized interventions such as gentle haptic patterns, guided micro-breathing exercises, or ambient audio cues to help restore balance without disrupting daily activities. Unlike traditional meditation or biofeedback apps, Mave’s wearable operates proactively and unobtrusively, learning the user’s unique patterns over time to provide increasingly tailored support.
The funding will enable Mave to complete clinical validation studies (in partnership with leading neuroscience institutes), secure CDSCO approval as a wellness device, scale small-batch manufacturing in India, and launch a consumer pilot in select cities by late 2026. The device will be subscription-free for core tracking and basic interventions, with optional premium features including advanced analytics, personalized coaching sessions, and integration with workplace wellness programs. Mave plans to target high-stress segments such as IT professionals, students preparing for competitive exams, healthcare workers, and corporate executives, while also exploring B2B partnerships for employee wellness initiatives.
The startup’s founders a mix of neuroscientists, engineers, and former consumer tech executives emphasized that India’s fast-paced work culture and rising mental health awareness create a massive opportunity for affordable, science-backed tools that empower users to manage focus and stress proactively. The company has already completed successful prototype trials with early users, showing measurable improvements in attention span, stress recovery time, and overall wellbeing scores. With the seed funding secured, Mave is now focused on refining the hardware for comfort and battery life, expanding its AI model with diverse Indian user data, and building a strong go-to-market strategy.
This funding round highlights continued investor enthusiasm for neurotech and mental wellness solutions in India, where wearable adoption is surging and demand for non-pharmacological stress management tools is growing rapidly. Mave Health is positioned to become a key player in the emerging category of AI-driven cognitive wearables, with potential to expand into sleep optimization, anxiety management, and neurorehabilitation in future iterations.
“In today’s high-pressure world, focus and calm shouldn’t be luxuries they should be skills anyone can strengthen. Our wearable makes that possible by bringing intelligent, personalized support directly to the wrist.”
By
HB Team
